Bio-Rad Laboratories (BIO-B) Raw Materials (2009 - 2022)

Bio-Rad Laboratories (BIO-B) has 14 years of Raw Materials data on file, last reported at $188.5 million in Q2 2022.

• Quarterly Raw Materials rose 56.87% year-over-year to $188.5 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $188.5 million (up 56.87% YoY) and the FY2021 annual result came in at $116.9 million, down 7.9% from the prior year.
• Raw Materials grew to $188.5 million in Q2 2022 per BIO-B's latest filing, from $146.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $188.5 million in Q2 2022 and bottomed at $104.0 million in Q1 2020.
• The 5-year median for Raw Materials is $118.3 million (2018), against an average of $123.3 million.
• The widest annual swing landed in 2021, when Raw Materials decreased 18.41%; it then jumped 56.87% in 2022.
• Tracing BIO-B's Raw Materials over 5 years: stood at $108.0 million in 2018, then increased by 1.45% to $109.6 million in 2019, then increased by 15.83% to $126.9 million in 2020, then decreased by 7.9% to $116.9 million in 2021, then surged by 61.26% to $188.5 million in 2022.
• Per Business Quant, the three latest BIO-B Raw Materials figures stand at $188.5 million (Q2 2022), $146.2 million (Q1 2022), and $116.9 million (Q4 2021).

Peer Comparison